Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly

Yuen, Kevin C.J.; Muñoz, Kathryn A.; Brook, Richard A.; Beren, IA; Whalen, John; Rohrbacker, Nicholas J.; Ribeiro‐Oliveira, Antônio

doi:10.1016/j.eprac.2021.04.412

Cited by 5 publications

(15 citation statements)

References 16 publications

(20 reference statements)

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Although studies focus on the impact of cancer on work absence, disability, and cost, studies in the literature using integrated employee benefits and payroll system data on caregivers are limited [14][15][16][17]. The trends reported in recent RRDb research has also been published on employee trends with mental disorders and substance use disorders [18] and rheumatoid arthritis [20] and cohort studies on acromegaly, [19] multiple sclerosis, [23] and other conditions [24][25][26][27][28][29].…”

Section: Discussionmentioning

confidence: 99%

“…The Workpartners RRDb has been leveraged to publish data on the impact from all four absence benefits using real-world data based on claims and payroll data [18][19][20][23][24][25][26][27][28][29]36] In the present study, annual cohort inclusion, prevalence, medical costs, and CCI were based on medical claims. Drug costs were derived from prescription claims, and the remaining outcomes were based on absence benefits.…”

Section: Discussionmentioning

confidence: 99%

“…The RRDb has also been used to study the impact on the employee-caregiver when a dependent child had pediatric asthma [17]. Recent RRDb research has also been published on employees with mental disorders and substance use disorders, [18] acromegaly, [19] and rheumatoid arthritis [20].…”

Section: Methodsmentioning

confidence: 99%

See 2 more Smart Citations

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees Whose Spouses have Cancer Conditions in the United States

2022

J Oncol Res Ther

View full text Add to dashboard Cite

Purpose: U.S. firms often include medical and prescription insurance for their employees and dependents as well as absence benefits for employees. Employers recognize that family illnesses can impact employee health and absences. This research compares all-cause absence utilization and changes from baseline for eligible employees whose spouses have cancer. Methods: Spouses with cancer healthcare claims were identified in the Workpartners database between January-2001 and December-2020 and analyzed retrospectively. Outcomes included annual prevalence (of spouse-patients with cancer), and for spouse-patients and employees: direct costs (medical and prescription) and overall severity. All-cause short-and long-term disability (STD and LTD, respectively), workers' compensation (WC), and sick leave (SL) benefit utilization, mean days of leave, and disability payments were analyzed for the employees for cancer overall and for specific cancer categories. Annual outcomes were calculated over the 20-year period. Trends were compared to detect differences from zero and across types of cancer. Results: At baseline (2001), 4.6% of employees' spouses had cancer, and among these employees, 45.5% used SL, 4.8% filed STD claims, 0.1% filed LTD claims, and 1.2% filed WC claims.

show abstract

Section: Discussionmentioning

confidence: 99%

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees Whose Spouses have Cancer Conditions in the United States

2022

J Oncol Res Ther

View full text Add to dashboard Cite

show abstract

“…Although many studies report using real-world data to examine the impact of cancer on work absence, disability, and cost, few studies in the literature use real-world, person-specific absence cost and lost time data from comprehensive employee benefits and payroll systems [19][20][21][22][23][24][25][26][27][28][29].…”

Section: Discussionmentioning

confidence: 99%

“…), vision and dental claims, plus payments and lost time for four absence benefits: sick leave, short-term disability, long-term disability, and workers' compensation. Employees in the RRDb with eligibility for the absence benefits are shown in Table 1.The RRDb has been used to analyze absence payments and lost productivity and trends for various conditions [19][20][21][22][23][24][25][26][27][28][29].…”

Section: Methodsmentioning

confidence: 99%

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees With Cancer Conditions in the United States

2022

J Oncol Res Ther

View full text Add to dashboard Cite

Purpose: Employee benefits in U.S. firms often include medical and prescription insurance and short-and long-term disability (STD and LTD, respectively), workers' compensation (WC), and discretionary sick leave (SL). Employers are intensifying their efforts to understand and manage employee disability and its relationship to important health conditions. This research compares all-cause STD/LTD/WC/SL utilization and changes from baseline for eligible employees with cancer. Methods: Employees incurring cancer medical claims over a 20-year period (ending 12/31/2020) were identified in the Workpartners database. The annual prevalence, direct all-cause medical and prescription costs, absence benefit utilization, mean days of leave, and disability payments were analyzed retrospectively overall, and for specific cancer categories. Annual outcomes were calculated over the 20-year period. Trend line slopes were compared to detect differences from zero and across types of cancer. Results: At baseline (2001), 3.4% of employees had cancer, 58.7% of whom used SL, 16.7% filed STD claims, 0.8% filed LTD claims, and 0.9% filed WC claims. Baseline mean medical and drug costs for employees with cancer were $7,330 and $1,039, respectively. From 2001 to 2020, cancer prevalence rates increased significantly, by 0.75 per 1000 employees per year. While medical costs, drug costs, and sick days per employee increased significantly, the percent of employees using SL, LTD, and WC decreased. Some significant differences in trends among cancer types were seen. Conclusions While medical and drug costs for employees with cancer have increased over 2001-2020, utilization of most absence benefits and disability payments for those absences as a percent of salary have not.

show abstract

The socioeconomic burden of acromegaly

Störmann

Cuny

2023

European Journal of Endocrinology

View full text Add to dashboard Cite

Acromegaly is a rare and insidious disease characterized by chronic excess growth hormone, leading to various morphological changes and systemic complications. Despite its low prevalence, acromegaly poses a significant socioeconomic burden on patients and healthcare systems. This review synthesizes the current state of knowledge on the psychosocial burden, disability, impact on daily life, and cost of acromegaly disease, focusing on quality of life, partnership, medical care and treatment afflictions, participation in daily activities, professional and leisure impairment, and cost of treatment for acromegaly and its comorbidities. It also examines management strategies, coping mechanisms, and interventions aimed at alleviating this burden. Comprehensive understanding of the extent of the socioeconomic burden in acromegaly is crucial to develop effective strategies to improve treatment and care. Further research is warranted to explore the myriad factors contributing to this burden, as well as the efficacy of interventions to alleviate it, ultimately enhancing the quality of life for patients with acromegaly.

show abstract

Health Benefit Costs and Absenteeism Among Employed Patients With Acromegaly

Cited by 5 publications

References 16 publications

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees Whose Spouses have Cancer Conditions in the United States

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees Whose Spouses have Cancer Conditions in the United States

Employer Paid Sick Leave, Disability, and Workers’ Compensation Trends for Employees With Cancer Conditions in the United States

The socioeconomic burden of acromegaly

Contact Info

Product

Resources

About